Pfizer subsidiary completes €3.3B debt offering in four tranches

PFIZER INC

Issued €750M 2.875% notes due 2029, €1B 3.250% notes due 2032, €750M 3.875% notes due 2037, €800M 4.250% notes due 2045.
Notes are fully and unconditionally guaranteed by Pfizer on a senior unsecured basis.
Offering completed on May 19, 2025 under existing shelf registration statement.
The debt raise adds €3.3B in long-term fixed-rate liabilities across maturities from 2029 to 2045.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.